These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Endometrial cancer and steroid hormone receptors]. Nyholm HC Ugeskr Laeger; 1990 Feb; 152(9):593-7. PubMed ID: 2408223 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of metastasizing carcinoma of the uterus with gestagens]. Engeler V Schweiz Med Wochenschr; 1971 Dec; 101(52):1906-9. PubMed ID: 5141283 [No Abstract] [Full Text] [Related]
5. Progestogens in the treatment of carcinoma of the endometrium. Kennedy BJ Surg Gynecol Obstet; 1968 Jul; 127(1):103-14. PubMed ID: 5657772 [No Abstract] [Full Text] [Related]
9. Do estrogen and progesterone receptors (E2R and PR) in metastasizing endometrial cancers predict the response to gestagen therapy? Benraad TJ; Friberg LG; Koenders AJ; Kullander S Acta Obstet Gynecol Scand; 1980; 59(2):155-9. PubMed ID: 7405552 [TBL] [Abstract][Full Text] [Related]
10. Endolymphatic stromal myosis: a case with positive estrogen and progesterone receptors and good response to progestins. Tsukamoto N; Kamura T; Matsukuma K; Imachi M; Uchino H; Saito T; Ono M Gynecol Oncol; 1985 Jan; 20(1):120-8. PubMed ID: 3965374 [TBL] [Abstract][Full Text] [Related]
11. Use of progestational agents in the management of metastatic carcinoma of the endometrium. Kistner RW; Griffiths CT Clin Obstet Gynecol; 1968 Jun; 11(2):439-56. PubMed ID: 4879374 [No Abstract] [Full Text] [Related]
12. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy]. Thurzó L; Sas M; Falkay G Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029 [No Abstract] [Full Text] [Related]
13. [Estrogen and progesterone receptors in corpus uteri carcinoma and their clinical significance]. Kleine W; Fuchs A; deGregorio G; Geyer H Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):884-7. PubMed ID: 6925560 [TBL] [Abstract][Full Text] [Related]
14. Identification of endocrine responsive breast and endometrial carcinoma using steroid hormone receptors. Wittliff JL; Day TG; Dean WL; Allegra JC Prog Clin Biol Res; 1988; 276():11-41. PubMed ID: 3051018 [No Abstract] [Full Text] [Related]
15. [Treatment of carcinoma corporis uteri using progesterone]. Igel H Zentralbl Gynakol; 1972 Aug; 94(33):1084-7. PubMed ID: 4116922 [No Abstract] [Full Text] [Related]
16. [On gestagen therapy of advanced corpus uteri cancer]. Schmidt-Matthiesen H; Wellers H Geburtshilfe Frauenheilkd; 1968 May; 28(5):417-27. PubMed ID: 5711400 [No Abstract] [Full Text] [Related]
17. [Estrogen and progesterone receptors in the assessment of endometrial carcinoma]. Gao YL Zhonghua Fu Chan Ke Za Zhi; 1984 Oct; 19(4):232-5, 258. PubMed ID: 6536440 [No Abstract] [Full Text] [Related]
18. [Estrogen and progesterone receptors in endometrial carcinoma following endometrial radiation therapy]. Thurzó L; Falkay G; Sas M Orv Hetil; 1985 Jan; 126(3):137-9. PubMed ID: 4038551 [No Abstract] [Full Text] [Related]
19. [Estrogen and progesterone receptor assay in the normal endometrium and endometrial carcinoma]. Li SY Zhonghua Zhong Liu Za Zhi; 1984 Nov; 6(6):429-31. PubMed ID: 6532745 [No Abstract] [Full Text] [Related]
20. Sex steroid receptors in endometrial cancer. Chambers JT Yale J Biol Med; 1988; 61(4):339-50. PubMed ID: 3055700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]